Reporting Manager
Alyeska Investment Group, L.P.
Symbol
TRAW
Shares outstanding
3,053,051 shares
Disclosed Ownership
302,252 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
14 Feb 2025, 16:22:54 UTC
Date of event
31 Dec 2024

Sponsored

Quoteable Key Fact

"Alyeska Investment Group, L.P. disclosed 9.9% ownership in Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW) on 31 Dec 2024."

Quick Takeaways

  • Alyeska Investment Group, L.P. filed SCHEDULE 13G for Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW).
  • Disclosed ownership: 9.9%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:22.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alyeska Investment Group, L.P. 9.9% 302,252 0 302,252 Jason Bragg Jason Bragg | Chief Financial Officer
Alyeska Fund GP, LLC 9.9% 302,252 0 302,252 Jason Bragg Jason Bragg | Chief Financial Officer
Anand Parekh 9.9% 302,252 0 302,252 Anand Parekh Anand Parekh | Self